Tag: pharma

Posted on March 5, 2019

Discovery Of New Drugs For Depression:

In experiments with mice, researchers at Johns Hopkins Medicine report a promising advance in the search for a new class of drugs to treat major depression. Read More

Posted on June 25, 2018

Biomarkers (ACPA) in Aggressive Rheumatoid Arthritis:

While treatments for rheumatoid arthritis have traditionally focused on targeting the disease’s inflammatory pathways, increasingly, research is pointing to a need to account for the role of autoantibodies in disease progression. One example: some people have a more highly active form of the disease that can lead to worse outcomes if left untreated or under-treated. […] Read More

Posted on December 9, 2015

HOW PHARMA CAN WIN IN THE DIGITAL WORLD: McKinsey- David Champagne (London), Amy Hung (New Jersey) & Olivier Leclerc (California)

The digital revolution continues to transform healthcare fundamentally, and many people believe that a tipping point is finally within reach. In 2014, digital health investments topped $6.5 billion, compared with $2.9 billion a year earlier.1 The critical question now for pharmaceutical companies is how to stay ahead of these changes. To answer it, we sought […] Read More

Posted on October 5, 2015

TRANSPARENCY IN PHARMA PRICING IS DEMANDED BY GOVERNMENT:

J. Michael Pearson has become a billionaire from his tough tactics as the head of the fast-growing Valeant Pharmaceuticals International. And consumers like Bruce Mannes, a 68-year-old retired carpenter from Grandville, Mich., are facing the consequences. Mr. Mannes has been taking the same drug, Cuprimine, for 55 years to treat Wilson disease, an inherited disorder […] Read More

Posted on September 25, 2015

U.S. DRUG COMPANY ALEXION IS SUING THE CANADIAN GOVERNMENT OVER PRICING OF SOLIRIS: CBC NEWS Sept 24 2015

A U.S. drug company is taking the Canadian government to court for its attempt to lower the price of what has been called the world’s most expensive drug. Alexion Pharmaceuticals has filed a motion in Federal Court, arguing that Canada’s drug price watchdog has no authority to force the company to lower its price for […] Read More

Posted on June 25, 2015

Spotlight on Alexion’s pricing of rare-disease drug Soliris; CBC News- Kelly Crowe- reporter.

Spotlight on Alexion’s pricing of rare-disease drug Soliris Cost of one of world’s most expensive drugs shrouded in corporate secrecy By Kelly Crowe, CBC News Posted: Jun 25, 2015 5:00 AM ET Last Updated: Jun 25, 2015 5:00 AM ET About The Author Kelly Crowe Medical science Kelly Crowe is a medical sciences correspondent for CBC […] Read More

Posted on May 13, 2015

ADVOCACY FOR COMPLEX DRUG CLAIMS: Raymond Rupert MD. MBA. Rupert Case Management Inc.

TAKING PATIENT ASSISTANCE PROGRAMS TO THE NEXT LEVEL: Raymond Rupert MD. MBA. Rupert Case Management Inc. 800 620 7551 INTRODUCTION TO BIOLOGICS: Biologics change everything. Smart medications that target the source of the disease are the foundation for personalized medicine. The treatment outcomes can be outstanding. Unfortunately, these medications are expensive and this has lead […] Read More